Journal Report

THERAPEUTIC ADVANCES IN HEMATOLOGY

Download PDF
Journal Information
Journal Title
THERAPEUTIC ADVANCES IN HEMATOLOGY
Publisher
SAGE PUBLICATIONS LTD
ISSN
2040-6207
E-ISSN
2040-6215
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓
2020 ✓
2019 ✓
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Targeted therapies in immune thrombocytopenia: Current landscape and future directions
Tomás José González-López
2026-10 Vol. 17
DOI: 10.1177/20406207261491929
Clinical features, treatment and outcomes of adult warm autoimmune hemolytic anemia: A multicenter retrospective cohort study
Wenru Yue, Jie Shao, Yihan Liu et al.
2026-10 Vol. 17
DOI: 10.1177/20406207261491919
Biomarkers in hematological malignancies: A narrative review of diagnostic, prognostic, and predictive applications
Harshal Chorya, Madhurima Maity, Pratyush Sachdeva et al.
2026-10 Vol. 17
DOI: 10.1177/20406207261497107
Clinical efficacy and safety of von Willebrand factor concentrate almost devoid of factor VIII in long-term prophylaxis study in patients older than 6 years with severe von Willebrand disease
Cédric Hermans, Balkis Meddeb, Quentin Van Thillo et al.
2026-10 Vol. 17
DOI: 10.1177/20406207261479591
Prognostic value of neutrophil-to-lymphocyte ratio among patients suffering from multiple myeloma: A systematic review and meta-analysis
Wenjing Du, Shuainan Wang, Jingyan Song et al.
2026-10 Vol. 17
DOI: 10.1177/20406207261495841
Real-world acute myeloid leukemia outcomes during a decade of molecular diagnostic expansion and azacitidine plus venetoclax adoption in Thailand: A single-center implementation cohort
Thanawat Rattanathammethee, Noppamas Panyasit, Piangrawee Niprapan et al.
2026-10 Vol. 17
DOI: 10.1177/20406207261503620
Polycythemia vera and JAK2 unmutated erythrocytosis: Overview of updates in diagnosis and management from 2026
Maria Georgiou, Natalia Curto-Garcia, Priya Sriskandarajah
2026-10 Vol. 17
DOI: 10.1177/20406207261495790
Low dose chidamide promotes inhibitory Fcγ receptorIIb expression on monocytes in ITP: A translational study of human ITP samples and ITP murine models
Hongyu Zhao, Wenjing Liu, Haoyi Wang et al.
2026-10 Vol. 17
DOI: 10.1177/20406207261491619
Emicizumab long-term outcomes and coagulation biomarkers in mild or moderate hemophilia A without inhibitors (HAVEN 6)
Cedric Hermans, Víctor Jiménez-Yuste, Giuliana Ventriglia et al.
2026-10 Vol. 17
DOI: 10.1177/20406207261475838
Establishing consensus-based recommendations on first-line ruxolitinib failure and transition for myelofibrosis in Korea: A modified Delphi study
Sung-Eun Lee, Seug Yun Yoon, Junshik Hong et al.
2026-10 Vol. 17
DOI: 10.1177/20406207261501028
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 5, 2026 01:22